Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 16 hours agoInvestors have put their hopes in Moderna's (MRNA 2.64%) next potential product, a respiratory syncytial virus (RSV) vaccine. The RSV vaccine promises to...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 11 hours agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Cramer's Lightning Round: 'I'm a believer' in Moderna
CNBC· 4 hours ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 1 day agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
Moderna shares target raised to $85 by Deutsche Bank By Investing.com
Investing.com· 5 days agoOn Thursday, Deutsche Bank (ETR:DBKGn) revised its price target for Moderna (NASDAQ:MRNA) shares,...